Toxoplasmosis in Sheep: Abortion Diagnosis, Seroprevalence, and One Health Approach

Introduction

Toxoplasmosis, caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii, is a leading infectious cause of ovine abortion, stillbirth, and neonatal mortality worldwide. The parasite exhibits a complex life cycle with felids as definitive hosts and a wide range of warm-blooded animals, including sheep, as intermediate hosts. In sheep, primary infection during gestation results in transplacental transmission of tachyzoites, leading to necrotizing placentitis and fetal death. Beyond its direct impact on flock productivity, ovine toxoplasmosis represents a significant zoonotic concern, as consumption of undercooked infected mutton or lamb is a major route of human infection. This article provides a comprehensive review of the pathophysiology of T. gondii in sheep, diagnostic strategies for abortion workups, global seroprevalence patterns, and the integration of control measures within a One Health framework.

Etiology and Life Cycle

Toxoplasma gondii is a coccidian parasite with a heteroxenous life cycle. The definitive host is the domestic cat and other felids, in which sexual reproduction occurs in the intestinal epithelium, leading to the shedding of unsporulated oocysts in feces. After sporulation in the environment (a process requiring 1 to 5 days of exposure to oxygen and appropriate temperature and humidity), oocysts become infective and can survive for months to years in soil, water, and on vegetation [1, 2].

Sheep acquire infection primarily through ingestion of sporulated oocysts from contaminated feed, water, or pasture. After ingestion, sporozoites excyst in the small intestine, invade intestinal epithelial cells, and differentiate into rapidly dividing tachyzoites. Tachyzoites disseminate via the bloodstream and lymphatics to a variety of tissues, including the placenta and fetal tissues. In immunocompetent non-pregnant sheep, the host immune response, particularly cell-mediated immunity involving interferon-gamma and cytotoxic T lymphocytes, forces the parasite to convert into slowly replicating bradyzoites that form tissue cysts, predominantly in the brain and skeletal muscle [3, 4]. These cysts persist for the life of the animal and are a source of infection for carnivores and humans.

Pathogenesis of Ovine Abortion

The hallmark of ovine toxoplasmosis is abortion, which typically occurs when a naive ewe ingests oocysts for the first time during pregnancy. The timing of infection relative to gestation is critical. Infection in early gestation (first trimester) often results in fetal death and resorption, sometimes with no outward clinical signs. Infection in mid-gestation (second trimester) leads to abortion, stillbirth, or the birth of weak lambs. Infection in late gestation (third trimester) may result in the birth of live, apparently healthy lambs that are congenitally infected [5, 6].

The pathophysiological mechanism involves the invasion of placental cotyledons by tachyzoites, leading to multifocal necrotizing placentitis. Grossly, the cotyledons appear mottled with white to yellow foci of necrosis, often described as "chalky" or "cheesy" lesions. The intercotyledonary areas may be thickened and edematous. Histologically, there is extensive necrosis of the trophoblast and chorionic epithelium, with infiltration of mononuclear cells, primarily macrophages and lymphocytes. Tachyzoites and tissue cysts can be identified within the lesions [7, 8]. Fetal infection occurs via the umbilical circulation, and the fetal brain and heart are common sites of parasite localization. Fetal lesions include multifocal nonsuppurative encephalitis with gliosis, perivascular cuffing, and microglial nodules. Myocardial necrosis and myositis are also frequently observed [9].

Diagnostic Strategies for Ovine Abortion

A definitive diagnosis of T. gondii as the cause of ovine abortion requires laboratory confirmation. A combination of serological and molecular methods applied to maternal serum, fetal fluids, and fetal tissues provides the highest diagnostic accuracy.

Serological Diagnosis

Serological detection of anti-T. gondii antibodies in maternal serum or fetal fluids is a primary diagnostic tool. The most widely used assays are commercial enzyme-linked immunosorbent assays (ELISA) and the indirect fluorescent antibody test (IFAT). The Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus provides a relevant technical parallel for understanding the principles of antigen-antibody binding in a solid-phase assay, though the target antigens differ.

In maternal serum, the detection of IgG and IgM antibodies is informative. A high IgG titer in a single sample from an aborting ewe is suggestive but not definitive, as IgG can persist for years. The presence of IgM antibodies indicates recent or active infection, typically within the preceding 2 to 4 months [10]. Paired serum samples (acute and convalescent) showing a four-fold rise in IgG titer provide stronger evidence of recent infection, though this is often impractical in a clinical abortion outbreak.

Fetal fluids (thoracic or peritoneal fluid) are a more specific sample. The detection of IgG in fetal fluid indicates an active fetal immune response, which is only possible after approximately 90 to 100 days of gestation when the fetal immune system becomes immunocompetent. A positive result in fetal fluid is highly indicative of congenital infection [11, 12].

Molecular Diagnosis

Polymerase chain reaction (PCR) is the method of choice for direct detection of T. gondii DNA in fetal tissues and placenta. The most commonly targeted genetic loci are the 529 bp repetitive element (REP-529), the B1 gene, and the internal transcribed spacer 1 (ITS-1) region. The REP-529 sequence is present in 200 to 300 copies per genome, providing superior analytical sensitivity compared to single-copy targets [13, 14].

Fetal brain, liver, lung, and placenta are the preferred tissues for PCR analysis. Placental tissue, particularly the cotyledons, often contains the highest parasite load. A positive PCR result confirms the presence of the parasite in the tissue but must be interpreted in conjunction with histopathology to establish causality. Quantitative PCR (qPCR) can provide an estimate of parasite burden, which correlates with the severity of placental lesions [15].

Histopathology and Immunohistochemistry

Histological examination of the placenta and fetal brain remains a cornerstone of diagnosis. Placental sections stained with hematoxylin and eosin (H&E) reveal characteristic foci of necrosis, mineralization, and mononuclear inflammation. The presence of T. gondii tachyzoites or tissue cysts can be confirmed using immunohistochemistry (IHC) with polyclonal or monoclonal antibodies directed against T. gondii antigens. IHC is particularly useful when tissue architecture is preserved and can differentiate T. gondii from other abortifacient agents such as Neospora caninum or Chlamydia abortus [16, 17].

Differential Diagnosis

Ovine abortion has multiple infectious etiologies that must be ruled out. Key differentials include Chlamydia abortus (enzootic abortion of ewes), Campylobacter fetus subspecies fetus, Salmonella enterica serovars, Listeria monocytogenes, Coxiella burnetii (Q fever), and Neospora caninum. A diagnostic panel that includes PCR for these agents, along with bacterial culture and serology, is recommended for comprehensive abortion investigation [18].

Diagnostic Workflow

The following Mermaid diagram illustrates a recommended diagnostic decision tree for investigating an ovine abortion outbreak suspected to be caused by T. gondii.

flowchart TD
    A[Abortion Outbreak in Flock], > B{Collect Samples}
    B, > C[Maternal Serum]
    B, > D[Fetal Fluids and Tissues]
    B, > E[Placenta]
    
    C, > F[ELISA for IgG/IgM]
    F, > G{High IgM or Rising IgG?}
    G, >|Yes| H[Recent Infection Likely]
    G, >|No| I[Chronic Exposure; Not Cause]
    
    D, > J[PCR for T. gondii DNA]
    E, > J
    J, > K{Positive?}
    K, >|Yes| L[Confirm with Histopathology/IHC]
    K, >|No| M[Consider Other Etiologies]
    
    L, > N{Lesions Consistent?}
    N, >|Yes| O[Diagnosis: Ovine Toxoplasmosis]
    N, >|No| P[Subclinical Infection; Not Cause]
    
    H, > O
    I, > Q[Investigate Other Pathogens]
    M, > Q
    P, > Q

Seroprevalence and Risk Factors

Seroprevalence of T. gondii in sheep varies widely across geographic regions, production systems, and management practices. Global seroprevalence estimates range from 10% to over 80% at the flock level, with individual animal prevalence typically between 20% and 60% [19, 20].

Geographic Variation

High seroprevalence rates are consistently reported in regions with large feral cat populations, warm and humid climates that favor oocyst sporulation and survival, and extensive grazing systems where sheep have greater exposure to contaminated pasture. Studies in South America, parts of Africa, and Southern Europe have reported seroprevalences exceeding 60% [21, 22]. Lower rates are observed in arid regions, intensive indoor production systems, and areas with effective rodent and cat control programs [23].

Management and Environmental Risk Factors

Several management factors are strongly associated with increased seroprevalence. The presence of cats on the farm, particularly young cats actively shedding oocysts, is the most significant risk factor [24]. Feeding sheep with hay or grain stored in areas accessible to cats can lead to contamination. Access to surface water sources such as ponds and streams that may be contaminated with cat feces is another important risk factor [25]. High stocking density and poor hygiene in lambing pens can facilitate the spread of oocysts. Age is also a factor; older ewes have a higher cumulative probability of exposure and thus higher seroprevalence than younger animals [26].

Breed and Genetic Susceptibility

Some studies suggest breed-related differences in susceptibility to clinical toxoplasmosis, though the evidence is not conclusive. Differences in immune response, particularly the efficiency of the Th1-type cell-mediated response, may influence the outcome of infection. However, no specific genetic markers for resistance or susceptibility have been definitively identified in sheep [27].

One Health Approach to Ovine Toxoplasmosis

Toxoplasmosis is a classic One Health issue, linking environmental contamination, animal health, and human disease. A comprehensive control strategy must address all three domains.

Zoonotic Risk from Sheep Meat

Human infection with T. gondii can occur through ingestion of oocysts from the environment or through consumption of undercooked meat containing viable tissue cysts. Sheep meat (mutton and lamb) is a well-documented source of human infection. The prevalence of T. gondii cysts in sheep meat at slaughter varies widely, with studies reporting detection rates of 5% to 50% in muscle samples, depending on the region and the sensitivity of the detection method [28, 29]. The highest cyst burdens are typically found in the diaphragm, heart, and skeletal muscles [30].

The risk to humans is mitigated by proper cooking (internal temperature of at least 63 degrees Celsius for whole cuts and 71 degrees Celsius for ground meat) and by freezing meat at minus 12 degrees Celsius or lower for several days, which reduces cyst viability [31]. However, consumer practices vary, and the risk remains significant in regions where raw or undercooked lamb is consumed.

Vaccination as a Control Tool

The only commercially available vaccine for ovine toxoplasmosis is a live attenuated vaccine based on the S48 strain of T. gondii. This strain was originally isolated from an aborted ovine fetus and has been passaged in mice and tissue culture to the point where it no longer forms tissue cysts. The vaccine is administered to naive ewes at least three weeks before mating and provides protection against transplacental infection for at least 18 months [32, 33].

The mechanism of protection is the induction of a strong cell-mediated immune response, including the production of interferon-gamma and cytotoxic T cells, which limits the proliferation and dissemination of tachyzoites upon challenge. Vaccination does not prevent infection but prevents the development of placentitis and subsequent abortion. Widespread vaccination in endemic flocks can significantly reduce abortion rates and the shedding of oocysts into the environment by reducing the number of infected placentas that are scavenged by cats [34, 35].

Environmental Management and Biosecurity

Reducing environmental contamination with oocysts is a critical control measure. This includes controlling the feral cat population on farms, preventing cats from accessing feed storage areas and lambing pens, and promptly removing and disposing of aborted fetuses and placentas (incineration or deep burial) to prevent scavenging [36]. Pasture management, such as rotational grazing and avoiding the use of contaminated water sources, can also reduce exposure. Composting of manure may reduce oocyst viability if temperatures exceed 55 degrees Celsius for extended periods [37].

Surveillance and Genotyping

Molecular surveillance of T. gondii strains circulating in sheep populations is important for understanding transmission dynamics and potential differences in pathogenicity. Genotyping is typically performed using multilocus PCR-restriction fragment length polymorphism (PCR-RFLP) or microsatellite analysis. In Europe and North America, the most common genotypes in sheep are Type II and Type III, with Type II being the most frequently associated with clinical abortion [38, 39]. Atypical and recombinant genotypes have been reported in South America and are associated with more severe disease in humans [40]. The integration of genomic data from livestock, wildlife, and human cases is a key component of a One Health surveillance system, as discussed in the context of Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications.

Conclusion

Toxoplasmosis remains a major cause of ovine reproductive loss and a significant zoonotic pathogen. Accurate diagnosis of abortion requires a systematic approach combining serology, PCR, and histopathology. High seroprevalence in many regions underscores the widespread nature of the parasite and the need for effective control. A One Health approach that integrates vaccination of ewes, environmental management to reduce oocyst contamination, and public education on meat handling is essential for reducing the burden of disease in both sheep and human populations. Continued research into improved diagnostics, vaccine efficacy, and the role of wildlife in parasite transmission will further enhance control strategies.

References

[1] Dubey JP. Toxoplasmosis of Animals and Humans. 2nd ed. CRC Press; 2010.

[2] Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12-13):1217-1258.

[3] Innes EA, Bartley PM, Buxton D, Katzer F. Ovine toxoplasmosis. Parasitology. 2009;136(14):1887-1894.

[4] Gazzinelli RT, Denkers EY, Sher A. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infect Agents Dis. 1993;2(3):139-149.

[5] Buxton D, Finlayson J. Experimental infection of pregnant sheep with Toxoplasma gondii: pathological and immunological observations. J Comp Pathol. 1986;96(3):319-333.

[6] Owen MR, Trees AJ. Vertical transmission of Toxoplasma gondii from chronically infected ewes to their lambs. Vet Rec. 1999;144(24):659-660.

[7] Buxton D, Maley SW, Wright SE, Thomson KM, Rae AG, Innes EA. The pathogenesis of experimental ovine toxoplasmosis. J Comp Pathol. 1994;111(3):259-275.

[8] Esteban-Redondo I, Maley SW, Thomson K, Nicoll S, Wright S, Buxton D, Innes EA. Detection of T. gondii in tissues of sheep and cattle following oral infection. Vet Parasitol. 1999;86(3):155-171.

[9] Dubey JP, Schares G, Ortega-Mora LM. Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev. 2007;20(2):323-367.

[10] Lunden A, Uggla A. Infectivity of Toxoplasma gondii in mutton following curing, smoking, freezing or microwave cooking. Int J Food Microbiol. 1992;15(3-4):357-363.

[11] Masala G, Porcu R, Madau L, Tanda A, Ibba B, Satta G, Tola S. Survey of ovine and caprine toxoplasmosis by IFAT and PCR assays in Sardinia, Italy. Vet Parasitol. 2003;117(1-2):15-21.

[12] Dubey JP, Kirkbride CA. Toxoplasmosis in sheep: a review and annotated bibliography. Vet Parasitol. 1989;32(4):291-310.

[13] Homan WL, Vercammen M, De Braekeleer J, Verschueren H. Identification of a 200- to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol. 2000;30(1):69-75.

[14] Reischl U, Bretagne S, Kruger D, Ernault P, Costa JM. Comparison of two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using fluorescence resonance energy transfer hybridization probes. BMC Infect Dis. 2003;3:7.

[15] Gutierrez J, O'Donovan J, Williams EJ, Proctor A, Brady C, Marques PX, Worrall S, Nally JE, McElroy M, Bassett H, Sammin D, Buxton D, Maley S, Markey BK. Detection and quantification of Toxoplasma gondii in ovine maternal and foetal tissues from experimentally infected pregnant ewes using real-time PCR. Vet Parasitol. 2010;172(1-2):8-15.

[16] Uggla A, Sjoland L, Lindberg R. Immunohistochemistry in the diagnosis of ovine toxoplasmosis. Vet Parasitol. 1987;24(3-4):169-178.

[17] Buxton D, Maley SW, Thomson KM, Trees AJ, Innes EA. Experimental infection of non-pregnant and pregnant sheep with Neospora caninum. J Comp Pathol. 1997;117(1):1-16.

[18] Menzies PI. Control of important causes of infectious abortion in sheep and goats. Vet Clin North Am Food Anim Pract. 2011;27(1):81-93.

[19] Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008;38(11):1257-1278.

[20] Tenter AM. Toxoplasma gondii in animals used for human consumption. Mem Inst Oswaldo Cruz. 2009;104(2):364-369.

[21] Garcia JL, Navarro IT, Ogawa L, de Oliveira RC, Kobilka E. Seroprevalence of Toxoplasma gondii in sheep from Parana State, Brazil. Vet Parasitol. 1999;83(3-4):289-294.

[22] van der Puije WN, Bosompem KM, Canacoo EA, Wastling JM, Akanmori BD. The prevalence of anti-Toxoplasma gondii antibodies in Ghanaian sheep and goats. Acta Trop. 2000;76(2):141-146.

[23] Skjerve E, Waldeland H, Nesbakken T, Kapperud G. Risk factors for the presence of antibodies to Toxoplasma gondii in Norwegian slaughter lambs. Prev Vet Med. 1998;35(3):219-227.

[24] Weigel RM, Dubey JP, Siegel AM, Kitron UD, Mannelli A, Mitchell MA, Mateus-Pinilla NE, Thulliez P, Shen SK, Kwok OC. Risk factors for transmission of Toxoplasma gondii on swine farms in Illinois. J Parasitol. 1995;81(5):736-741.

[25] Meerburg BG, Kijlstra A. Changing climate-changing pathogens: Toxoplasma gondii in North-Western Europe. Parasitol Res. 2009;105(1):17-24.

[26] Klun I, Djurkovic-Djakovic O, Katic-Radivojevic S, Nikolic A. Cross-sectional survey on Toxoplasma gondii infection in cattle, sheep and pigs in Serbia: seroprevalence and risk factors. Vet Parasitol. 2006;135(2):121-131.

[27] Innes EA, Vermeulen AN. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology. 2006;133 Suppl:S145-S168.

[28] Aspinall TV, Marlee D, Hyde JE, Sims PF. Prevalence of Toxoplasma gondii in commercial meat products as monitored by polymerase chain reaction and food safety. J Food Prot. 2002;65(7):1154-1158.

[29] Tenter AM, Vietmeyer C, Johnson AM, Janitschke K, Rommel M, Lehmacher W. Detection of Toxoplasma gondii in tissues of experimentally infected sheep by PCR and isolation. J Vet Med B Infect Dis Vet Public Health. 1994;41(7-8):529-540.

[30] Dubey JP. Long-term persistence of Toxoplasma gondii in tissues of pigs inoculated with T. gondii oocysts and effect of freezing on viability of tissue cysts in pork. Am J Vet Res. 1988;49(6):910-913.

[31] Kijlstra A, Jongert E. Control of the risk of human toxoplasmosis transmitted by meat. Int J Parasitol. 2008;38(12):1359-1370.

[32] Buxton D, Thomson KM, Maley S, Wright S, Bos HJ. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet Rec. 1991;129(5):89-93.

[33] O'Connell E, Wilkins MF, Te Punga WA. Toxoplasmosis in sheep. II. The ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii. N Z Vet J. 1988;36(1):1-4.

[34] Innes EA, Bartley PM, Rocchi M, Benavides-Silvan J, Burrells A, Hotchkiss E, Chianini F, Canton G, Katzer F. Developing vaccines to control protozoan parasites in ruminants: dead or alive? Vet Parasitol. 2011;180(1-2):155-163.

[35] Katzer F, Canton G, Burrells A, Palarea-Albaladejo J, Horton B, Bartley PM, Pang Y, Chianini F, Innes EA, Benavides J. Immunization of lambs with the S48 strain of Toxoplasma gondii reduces tissue cyst burden following oral challenge with a complete strain of the parasite. Vet Parasitol. 2014;205(1-2):46-56.

[36] Frenkel JK, Dubey JP. Toxoplasmosis and its prevention in cats and man. J Infect Dis. 1972;126(6):664-673.

[37] Jones JL, Dubey JP. Waterborne toxoplasmosis: recent developments. Exp Parasitol. 2010;124(1):10-25.

[38] Ajzenberg D, Cogne N, Paris L, Bessieres MH, Thulliez P, Filisetti D, Pelloux H, Marty P, Darde ML. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis. 2002;186(5):684-689.

[39] Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis. 1995;172(6):1561-1566.

[40] Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139(11):1375-1424.

[41] Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Vet Res. 1998;29(3-4):289-310.

[42] Esteban-Redondo I, Innes EA. Toxoplasma gondii infection in sheep and cattle. Comp Immunol Microbiol Infect Dis. 1997;20(2):191-196.

[43] Dubey JP, Beattie CP. Toxoplasmosis of Animals and Man. CRC Press; 1988.

[44] Blewett DA, Watson WA. The epidemiology of ovine toxoplasmosis. II. Possible sources of infection in outbreaks of clinical disease. Br Vet J. 1984;140(6):546-555.

[45] Waldeland H. Toxoplasmosis in sheep. The relative importance of the infection as a cause of reproductive loss in sheep in Norway. Acta Vet Scand. 1977;18(2):237-247.

[46] Hartley WJ, Marshall SC. Toxoplasmosis as a cause of ovine perinatal mortality. N Z Vet J. 1957;5(4):119-124.

[47] Munday BL, Mason RW. Toxoplasmosis as a cause of perinatal mortality in sheep. Aust Vet J. 1979;55(10):485-486.

[48] Dubey JP, Welcome FL. Toxoplasma gondii-induced abortion in sheep. J Am Vet Med Assoc. 1988;193(6):697-700.

[49] Trees AJ, Williams DJ. Vaccination against ovine toxoplasmosis. Vet Rec. 1991;129(5):89-90.

[50] Innes EA. Toxoplasmosis: comparative species susceptibility and host immune response. Comp Immunol Microbiol Infect Dis. 1997;20(2):131-138.